Frederick Millard

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207.

D. Bajorin, E. Small, J. Rosenberg, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.

J. Herndon, N. Vogelzang, M. Green, 2001, Lung cancer.